9 hrs ago
Feinstein Institute Receives $223,979 Small Business Technology Transfer Award In Partnership With
The Feinstein Institute for Medical Research, in partnership with Traverse Biosciences, has secured a $223,979 Phase I Small Business Technology Transfer award from the National Institute on Aging , part of the National Institutes of Health .
Ampio Pharmaceuticals, Inc. Announces The Opening Of Its New...
This factory is designed to manufacture and package 10 million doses per year of AmpionTM as an injectable drug for the treatment of osteoarthritis as well as for additional formulations of AmpionTM to treat other clinical indications.
Cytonics' Breakthrough Research Is Validated by Independent Study on A2M
Cytonics Corporation, an orthopedic research and development company, announced today that a recent peer-reviewed paper from an independent lab has validated Cytonics' lead therapeutic, alpha-2-macroglobulin, as an effective treatment for post-traumatic osteoarthritis.
MKSAP: 64-year-old man with knee osteoarthritis
A 64-year-old man is evaluated for a 2-year history of knee osteoarthritis. He has bilateral knee pain that worsens with walking.
Vascular network bio-printing brings 3D-printed organs one step closer
Scientists have come a step closer to being able to 3D-print biological tissue with integrated blood vessels, similar to these natural ones The ability to bio-print tissues and organs could one day allow us to create custom body parts that could be used for transplants.
Treating Osteoarthritis in your feline
Osteoarthritis is not curable, still treatment can significantly improve the feline's life.